ArticleEJHaem2023

GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance.

Aki Inase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.